Ignite Creation Date:
2025-12-26 @ 10:17 PM
Ignite Modification Date:
2025-12-31 @ 11:32 PM
Study NCT ID:
NCT01959412
Status:
COMPLETED
Last Update Posted:
2015-05-06
First Post:
2013-10-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Crossover Study to Evaluate the Efficacy, Safety and Tolerability of Different Doses of Indacaterol in Patients With Persistent Asthma
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-11
Start Date Type:
None
Primary Completion Date:
2014-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2014-03
Completion Date Type:
ACTUAL
First Submit Date:
2013-10-08
First Submit QC Date:
None
Study First Post Date:
2013-10-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-03-16
Results First Submit QC Date:
None
Results First Post Date:
2015-05-06
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-04-20
Last Update Post Date:
2015-05-06
Last Update Post Date Type:
ESTIMATED